BlackRock »

Avalo Therapeutics Ord shares owned by BlackRock

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by BlackRock

Quarter filed Position value Share count Share price at filing
2024-03-31 $46k 2.1k 21.75

More positions owned by BlackRock

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)

View all positions for BlackRock

Top funds holding Avalo Therapeutics Ord

Ikarian Capital
Sio Capital Management
UBS Group
ADAR1 Capital Management
Natixis
BlackRock
Tower Research Capital
Banque Cantonale Vaudoise
Royal Bank of Canada
Morgan Stanley
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc
Group One Trading
Jpmorgan Chase & Co
Advisor Group Holdings

View all funds holding Avalo Therapeutics Ord